TR200003082T2 - Treatment of general anxiety disorder with paroxetine - Google Patents

Treatment of general anxiety disorder with paroxetine

Info

Publication number
TR200003082T2
TR200003082T2 TR2000/03082T TR200003082T TR200003082T2 TR 200003082 T2 TR200003082 T2 TR 200003082T2 TR 2000/03082 T TR2000/03082 T TR 2000/03082T TR 200003082 T TR200003082 T TR 200003082T TR 200003082 T2 TR200003082 T2 TR 200003082T2
Authority
TR
Turkey
Prior art keywords
treatment
paroxetine
anxiety disorder
general anxiety
general
Prior art date
Application number
TR2000/03082T
Other languages
Turkish (tr)
Inventor
Zaninelli Rocco
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR200003082T2 publication Critical patent/TR200003082T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Bu bulus, genel endise bozuklugunun tedavisi ve özellikle de böyle bir tedavide paroksetinin kullanilmasi ile ilgilidir.This invention relates to the treatment of generalized disorder and particularly to the use of paroxetine in such treatment.

TR2000/03082T 1998-04-22 1999-04-22 Treatment of general anxiety disorder with paroxetine TR200003082T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9808479.1A GB9808479D0 (en) 1998-04-22 1998-04-22 Method of treatment

Publications (1)

Publication Number Publication Date
TR200003082T2 true TR200003082T2 (en) 2001-01-22

Family

ID=10830715

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03082T TR200003082T2 (en) 1998-04-22 1999-04-22 Treatment of general anxiety disorder with paroxetine

Country Status (20)

Country Link
EP (1) EP1073437A4 (en)
JP (1) JP2002512189A (en)
KR (1) KR20010034817A (en)
CN (1) CN1298301A (en)
AP (1) AP2000001959A0 (en)
AU (1) AU3864899A (en)
BG (1) BG104939A (en)
BR (1) BR9909791A (en)
CA (1) CA2328896A1 (en)
CZ (1) CZ20003885A3 (en)
EA (1) EA200001088A1 (en)
GB (1) GB9808479D0 (en)
HU (1) HUP0101350A3 (en)
ID (1) ID27546A (en)
IL (1) IL139167A0 (en)
NO (1) NO20005286L (en)
PL (1) PL343494A1 (en)
SK (1) SK15672000A3 (en)
TR (1) TR200003082T2 (en)
WO (1) WO1999053919A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2297550B (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
CN1298301A (en) 2001-06-06
BG104939A (en) 2001-09-28
ID27546A (en) 2001-04-12
CA2328896A1 (en) 1999-10-28
BR9909791A (en) 2000-12-26
EP1073437A1 (en) 2001-02-07
JP2002512189A (en) 2002-04-23
NO20005286D0 (en) 2000-10-20
PL343494A1 (en) 2001-08-27
WO1999053919A1 (en) 1999-10-28
SK15672000A3 (en) 2001-04-09
KR20010034817A (en) 2001-04-25
GB9808479D0 (en) 1998-06-17
NO20005286L (en) 2000-12-20
HUP0101350A3 (en) 2002-06-28
EA200001088A1 (en) 2001-04-23
EP1073437A4 (en) 2003-04-16
AU3864899A (en) 1999-11-08
HUP0101350A2 (en) 2002-05-29
IL139167A0 (en) 2001-11-25
AP2000001959A0 (en) 2000-12-31
CZ20003885A3 (en) 2001-09-12

Similar Documents

Publication Publication Date Title
TR200102029T2 (en) 1-Heterocyclyl substituted diarylamines.
TR199902033T2 (en) Sulfonylura-glitazone synergistic combinations for diabetes.
TR200201887T2 (en) Aqueous elastomer coating composition and objects coated with it.
TR199801302T2 (en) Substituted aza and diazacyclopentane and cyclooctane compounds.
PT1140944E (en) EPOTILONE DERIVATIVES AND THEIR USE AS ANTITUMATIC AGENTS
ATE314371T1 (en) SPIRO-INDOLE AS Y5 RECEPTOR ANTAGONISTS
BR0111298A (en) Selective androgen receptor modulators and methods for their identification, design and use
TR199801255T2 (en) Vitronectin receptor antagonists.
ATE335814T1 (en) MODIFIED ARGINE INDEAMINASE
DE60234269D1 (en) SUBSTITUTED ARYL 1,4-PYRAZINE DERIVATIVES
TR200101858T2 (en) 4-aryloxindoles as JNK protein kinase inhibitors
TR199801390T2 (en) Anticoagulants to be used in the treatment of thrombosis
BR9707233A (en) Phenanthridines
TR200002616T2 (en) Inhibition of raf kinase using symmetric and asymmetrically substituted diphenyl ureas
TR199501441A2 (en) Functional polyorganosiloxanes and one of the processes for their preparation.
DK0889886T3 (en) Novel, 6-position substituted phenanthridines
PT998460E (en) NEW TETRAZOLE DERIVATIVES
DK0827537T3 (en) Chromatin regulator genes
TR200002860T2 (en) New crystal forms of an antiviral benzimidazole composition.
ATE224351T1 (en) TRIS-SUBSTITUTED PHENYL DERIVATIVES WITH RETINOID AGONIST, ANTAGONIST OR INVERSAGONIST BIOLOGICAL ACTIVITY
TR199802704T2 (en) Use of combinations containing Vx478, Zidovidin, FTC and/or 3TC in the treatment of HIV.
TR200100462T2 (en) Muscarinic agonists and antagonists
DK1109810T3 (en) Benzonaphthydine N-oxides with PDE3 and PDE4 inhibitory activity
PT1086096E (en) BENZAMIDES WITH ETRA-HYDROFURANILOXI SUBSTITUTS AS PHOSPHODIESTERASE 4 INHIBITORS
DK1540335T3 (en) Screening methods for cognitive amplifiers